About
Paulex Bio is developing an oral medicine aimed at regenerating beta cells to treat type 1 and type 2 diabetes by addressing the root cause of the disease.
Explore Paulex Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.